Tiger Eye Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$26.1M |
| 2 |
GRA
W.R. Grace & Co.
GRA
|
+$22.5M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$20.7M |
| 4 |
Williams Companies
WMB
|
+$15M |
| 5 |
ESL
Esterline Technologies
ESL
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altisource Portfolio Solutions
ASPS
|
+$32.5M |
| 2 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$29.7M |
| 3 |
Comcast
CMCSA
|
+$22.4M |
| 4 |
AAMC
Altisource Asset Management Corp
AAMC
|
+$20.9M |
| 5 |
ONIT
Onity Group
ONIT
|
+$18.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 28.36% |
| 2 | Consumer Discretionary | 16.05% |
| 3 | Communication Services | 14.96% |
| 4 | Energy | 14.28% |
| 5 | Healthcare | 11.95% |
Similar funds
Tiger Eye Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Tiger Eye Capital held 65 positions worth $674M, down 16% from $799M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Tiger Eye Capital withdrew a net $161M in Q1 2014, closing 24 positions and reducing 17 holdings. Its most notable exit was Altisource Portfolio Solutions, an estimated $32.5M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 28% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Tiger Eye Capital opened a new position in Allergan plc worth $27.1M.
- Tiger Eye Capital's largest Q1 2014 buy was Allergan plc: 131,862 shares worth $27.1M.
- Tiger Eye Capital added most to W.R. Grace & Co. in Q1 2014, an estimated $22.5M increase.
- Tiger Eye Capital's biggest Q1 2014 reduction was QVC Group Inc Series A, cutting an estimated $29.7M.
- Tiger Eye Capital fully exited Altisource Portfolio Solutions in Q1 2014, selling an estimated $32.5M.
- Tiger Eye Capital's ten largest holdings make up 59% of its $674M portfolio in Q1 2014.
- Tiger Eye Capital opened 14 new positions and closed 24 in Q1 2014.
- Tiger Eye Capital's portfolio value fell 16% quarter-over-quarter to $674M.
Based on Tiger Eye Capital's 13F filing for Q1 2014, filed 14 May 2014.